These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9378983

  • 1. Cytokines promote glomerular mesangial cell survival in vitro by stimulus-dependent inhibition of apoptosis.
    Mooney A, Jobson T, Bacon R, Kitamura M, Savill J.
    J Immunol; 1997 Oct 15; 159(8):3949-60. PubMed ID: 9378983
    [Abstract] [Full Text] [Related]

  • 2. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.
    Minshall C, Arkins S, Straza J, Conners J, Dantzer R, Freund GG, Kelley KW.
    J Immunol; 1997 Aug 01; 159(3):1225-32. PubMed ID: 9233617
    [Abstract] [Full Text] [Related]

  • 3. Trophic support promotes survival of bcl-x-deficient telencephalic cells in vitro.
    Shindler KS, Yunker AM, Cahn R, Zha J, Korsmeyer SJ, Roth KA.
    Cell Death Differ; 1998 Oct 01; 5(10):901-10. PubMed ID: 10203689
    [Abstract] [Full Text] [Related]

  • 4. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide.
    Tamatani M, Ogawa S, Nuñez G, Tohyama M.
    Cell Death Differ; 1998 Oct 01; 5(10):911-9. PubMed ID: 10203697
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
    Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M.
    Eur J Immunol; 1996 Feb 01; 26(2):294-9. PubMed ID: 8617294
    [Abstract] [Full Text] [Related]

  • 6. Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors.
    Minshall C, Arkins S, Dantzer R, Freund GG, Kelley KW.
    J Immunol; 1999 Apr 15; 162(8):4542-9. PubMed ID: 10201993
    [Abstract] [Full Text] [Related]

  • 7. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
    Giuliano M, Lauricella M, Vassallo E, Carabillò M, Vento R, Tesoriere G.
    Invest Ophthalmol Vis Sci; 1998 Jul 15; 39(8):1300-11. PubMed ID: 9660477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .
    Kitamura M, Sütö T, Yokoo T, Shimizu F, Fine LG.
    J Immunol; 1996 Apr 15; 156(8):2964-71. PubMed ID: 8609417
    [Abstract] [Full Text] [Related]

  • 11. Dissociation of cytokine signals for proliferation and apoptosis.
    Shi Y, Wang R, Sharma A, Gao C, Collins M, Penn L, Mills GB.
    J Immunol; 1997 Dec 01; 159(11):5318-28. PubMed ID: 9548471
    [Abstract] [Full Text] [Related]

  • 12. Regulation of fibronectin by insulin-like growth factor-I in cultured rat thoracic aortic smooth muscle cells and glomerular mesangial cells.
    Tamaroglio TA, Lo CS.
    Exp Cell Res; 1994 Dec 01; 215(2):338-46. PubMed ID: 7982472
    [Abstract] [Full Text] [Related]

  • 13. Increased apoptosis susceptibility in mesangial cells from spontaneously hypertensive rats.
    Rodríguez-López AM, Flores O, Martínez-Salgado C, Eleno N, López-Novoa JM, Arévalo M.
    Microvasc Res; 2000 Jan 01; 59(1):80-7. PubMed ID: 10625574
    [Abstract] [Full Text] [Related]

  • 14. Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system.
    Russo VC, Kobayashi K, Najdovska S, Baker NL, Werther GA.
    Brain Res; 2004 May 29; 1009(1-2):40-53. PubMed ID: 15120582
    [Abstract] [Full Text] [Related]

  • 15. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G, Sailaja D.
    Invest Ophthalmol Vis Sci; 2004 Oct 29; 45(10):3577-88. PubMed ID: 15452065
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs.
    Dunn SE, Hardman RA, Kari FW, Barrett JC.
    Cancer Res; 1997 Jul 01; 57(13):2687-93. PubMed ID: 9205078
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts.
    Tamm I, Kikuchi T.
    J Cell Physiol; 1990 Jun 01; 143(3):494-500. PubMed ID: 2193035
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal.
    Wynes MW, Frankel SK, Riches DW.
    J Leukoc Biol; 2004 Nov 01; 76(5):1019-27. PubMed ID: 15316031
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
    Remacle-Bonnet MM, Garrouste FL, Heller S, André F, Marvaldi JL, Pommier GJ.
    Cancer Res; 2000 Apr 01; 60(7):2007-17. PubMed ID: 10766192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.